Iantosca, M R <br/><br/>
Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line.  [electronic resource] 

 -  Journal of neuroscience research  May 1999 
 - 248-58 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0360-4012 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-4547(19990501)56:3<248::AID-JNR4>3.0.CO;2-U  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Bone Morphogenetic Protein 2<br/>Bone Morphogenetic Protein 4<br/>Bone Morphogenetic Protein 6<br/>Bone Morphogenetic Protein Receptors<br/>Bone Morphogenetic Proteins--pharmacology<br/>Cell Count--drug effects<br/>Cell Division--drug effects<br/>Cell Nucleus--drug effects<br/>Cerebellum--cytology<br/>DNA Fragmentation--drug effects<br/>Dose-Response Relationship, Drug<br/>Ectoderm--cytology<br/>Glial Cell Line-Derived Neurotrophic Factor<br/>Humans<br/>Nerve Growth Factors<br/>Nerve Tissue Proteins--pharmacology<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>RNA, Messenger--genetics<br/>Receptors, Cell Surface--genetics<br/>Receptors, Growth Factor<br/>Transforming Growth Factor beta--pharmacology<br/>Tumor Cells, Cultured